ESC 365 - Diagnosis and risk stratification in hypertrophic obstructive cardiomyopathy

ESC Professional Premium Access

Diagnosis and risk stratification in hypertrophic obstructive cardiomyopathy

Session: Septal reduction and myosin inhibitors: competing or complementary therapies?

Topic: Myocardial Disease

Speaker: Professor C. Manisty (London, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Charlotte Manisty

University College London, London (United Kingdom of Great Britain & Northern Ireland)

20 presentations

2 followers

3 more presentations in this session

Transcatheter intervention in hypertrophic obstructive cardiomyopathy

Speaker: Doctor M. Michels (Rotterdam, NL)

What to expect from modern septal myectomy: is this still the gold standard?

Speaker: Doctor E. Quintana (Barcelona, ES)

American experience with use of myosin inhibitors: chemical myectomy or false enthusiasm?

Speaker: Doctor M. Maron (Burlington, US)

Access the full session

Septal reduction and myosin inhibitors: competing or complementary therapies?

Speakers: Professor C. Manisty, Doctor M. Michels, Doctor E. Quintana, Doctor M. Maron

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources